Fundraising Fox
Forcefield Therapeutics
8 employees on LinkedIn · 2 known investors
Find your way into Forcefield Therapeutics
Sign up to see every warm intro you have to Forcefield Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Forcefield Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Forcefield Therapeutics develops cardioprotective proteins for the treatment of cardiac disease, with an initial focus on myocardial infarction (heart attack). It holds an exclusive licence to these proteins and operates a virtual business model working with strategic and operational partners.
Founders & leadership
J
John
Investors · 2
Frequently asked questions
- What does Forcefield Therapeutics do?
- Forcefield Therapeutics develops cardioprotective proteins for the treatment of cardiac disease, with an initial focus on myocardial infarction (heart attack). It holds an exclusive licence to these proteins and operates a virtual business model working with strategic and operational partners.
- Who are Forcefield Therapeutics's investors?
- Forcefield Therapeutics's investors include Syncona, Roche Venture Fund.